BGI Group, one of the country's leading gene sequencing firms, is stepping up efforts to turn its life-science research and industrial capabilities into consumer products, signaling a strategic push to capitalize on everyday health, nutrition, skincare, and pet care markets.
Yang Shuang, senior vice-president at the company, said BGI's long-term goal is to extend life-science technologies beyond laboratories and professional settings into "daily life scenarios", building what he described as a multi-tier consumer health ecosystem anchored in genomics.
In the past, genetic technology was mostly understood by the public as scientific research, clinical use, or high-end testing technology, Yang said. "But with declining sequencing costs, the miniaturization of equipment, advances in artificial intelligence capabilities, and growing consumer health awareness, life science technology is moving out of professional institutions and heading into households, communities and everyday consumption scenarios."
High-end technology becoming more accessible to the public, health management becoming more proactive, and consumer products becoming more technology-empowered will constitute key industry trends going forward, Yang added.
